Scientific Program

Look for updates on the scientific program for the 16th International Ultmann Chicago Lymphoma Symposium

Friday, April 12, 2019

Nursing Session
7:00 AM – 8:00 AMRegistration and Breakfast
8:00 AM – 9:15 AMWelcome & An Overview of the Diagnosis, Prognosis, and Evolving Treatments of Lymphoma
9:15 AM – 9:30 AMBreak
9:30 AM – 11:30 AMFocus on Survivorship: Short-term and Long-term Toxicity from Pharmacy and Nursing Perspective
General Session
1:00 PM – 1:10 PMIntroductions
1:10 PM – 1:40 PMCan we identify high-­‐risk follicular lymphoma before starting treatment?
Robert Kridel, MD, MPH, PhD
1:40 PM – 2:10 PMLiquid Biopsies: Ready for Use in Lymphoma?
Mark Roschewski, MD
2:10 PM – 2:40 PMCAR T-Cell Therapy: Who, How, and Which One
Sattva Neelapu, MD
2:40 PM – 3:00 PMBreak
3:00 PM – 3:30 PMInherited Cancer Risk in Lymphoid Malignancies: What Do We Tell Our Patients?
Jane Churpek, MD
3:30 PM – 4:00 PMHarnessing Epigenetics in the Treatment of Lymphoma
Jennifer Amengual, MD
4:00 PM – 4:30 PMTargeting Apoptosis in Lymphoid Malignancies: More Than One Tool in the
Shed?
Alexey Danilov, MD, PhD
4:30 PM – 5:30 PMUsing Molecular and Cytogenetic Information to Sequence Treatment in CLL in
2019
John Seymour, MD, MPH
5:30 PM – 6:30 PMWrap Up/Reception & Poster Viewing

Saturday, April 13, 2019

General Session
7:00 AM -­‐8:00 AM Registration and Breakfast
8:00 AM -­‐8:10 AMIntroductions
8:10 AM -­‐ 8:40 AMCAR T-­‐cell Therapy: Patient Identification and Integration into Practice
Caron Jacobson, MD
8:40 AM - 9:10 AMNewly-Diagnosed MCL: Risk Stratification and Optimal Treatment
Andre Goy, MD, MS
9:10 AM -­‐10:00 AMState of the Art Treatment Approach for Newly-­‐diagnosed T-­‐cell Lymphoma
Pier Luigi Zinzani, MD, PhD
10:00 AM -­‐ 10:20 AMBreak
10:20 AM -­‐ 11:00 AMDebate #1: Allogeneic Stem Cell Transplant Still Has a Role in Hodgkin
Lymphoma
Miguel Perales, MD-­‐PRO l Craig Moskowitz, MD-­‐CON
11:00 AM -­‐ 11:30 AMShould AYA Lymphoma Patients Be Treated as Children or Adults?
Lisa Roth, MD
11:30 AM -­‐ 12:00 PMCardio-­‐oncology in Lymphoma: How and Why?
Jeanne DeCara, MD
12:00 PM -­‐ 12:45PMLunch
12:45 PM -­‐ 1:15 PMStaging and Restaging in Lymphoma: From Cheson to Lugano to RECIL
Mitchell Smith, MD, PhD
1:15 PM -­‐ 1:45 PMDefinition and Optimal Application of “Real World” Data in CLL
Anthony Mato, MD, MSCE
1:45 PM -­‐ 2:15 PMSurrogate End-­‐points in Lymphoma: When do we tell patients, they are “cured”?
Matthew Maurer, MD
2:15 PM -­‐ 2:55 PMDebate #2: Treatment of Follicular Lymphoma Without Chemotherapy
Loretta Nastoupil, MD-­‐PRO l Carla Casulo, MD-­‐CON
2:55 PM -­‐ 3:00 PMWrap Up